CUSIP 37611X100CL A SHSDNA4EURQ1 2025
50 filings · latest Feb 12, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Boston Standard Wealth Management, LLC | 606.6K | $203.0K |
| 4 | Nov 5, 2024 | Baillie Gifford &Amp; Co | 13G/A | 7.8% | 15.57M | SEC |
| 5 | Nov 4, 2024 | Baillie Gifford &Amp; Co | 13G/A | 5.6% | 5.44M | SEC |
| 6 | Nov 4, 2024 | Baillie Gifford &Amp; Co | 13G/A | 9.2% | 25.24M | SEC |
| 7 | Nov 4, 2024 | Baillie Gifford &Amp; Co | 13G/A | 14.5% | 6.54M | SEC |
| 8 | Jul 5, 2024 | Baillie Gifford & Co | 13G/A | 7.9% | 134.43M | SEC |
| 9 | Feb 14, 2024 | Knight Thomas F. Jr. | 13G/A | 4.1% | 68.33M | SEC |
| 10 | Feb 14, 2024 | Che Austin | 13G/A | 5.6% | 95.90M | SEC |
See the full Schedule 13D/13G history for Ginkgo Bioworks Holdings Inc.
Unlock full history